2C-B-FLY #
| Common Nomenclature | 2C-B-FLY |
| Street & Reference Names | N/A |
| Reference Dosage | Light 5mg+; Common 10mg+; Strong 18mg+; Heavy 25mg+ [TripSit] Threshold 2mg+; Light 5mg+; Common 10mg+; Strong 18mg+; Heavy 25mg+ [Psychonautwiki] |
| Anticipated: Onset / Duration | 1 Hour / 7 Hours |
| Maximum Dose Experienced | 10mg *[See also 4.10 Supplementary Notes] |
| Form | Pill & Powder |
| RoA | Oral & Insufflated |
| Source / Jurisdiction | Internet / UK |
| Personal Rating On Shulgin Scale | ++ |
SUBJECTIVE EXPERIENCE #
2C-B-FLY was first synthesised in 1996 by Aaron P. Monte, and by 2005 it had become sufficiently popular to merit its own Erowid vault. However, its popularity waned when a couple of deaths were erroneously linked to it, circa 2009. The chemical involved in these incidents was actually Bromo-DragonFly, which has a far lower threshold and a much higher toxicity. This had been mislabelled as 2C-B-FLY.
Notwithstanding this confusion, 2C-B-FLY made a comeback at the start of 2016, when it was released online by Lizard Labs. It was one of the few working psychedelics readily and legally available on the open market at the time of the generic UK ban in May of that year.
Prior to this date, I sampled this on a number of occasions, usually orally, and largely in the 10mg-15mg range.
Whilst it lacked the depth of 1p-LSD (which was similarly available), it was shorter lasting, and came with entactogenic body tingles and its own feel.
I didn’t find the headspace to be as clear or rewarding as that provided by lysergamides: despite a change in perception, it induced less insight, and less of a feeling of oneness and spirituality. This is not to say that these were totally absent.
It was fun in its own right, and was perhaps a twist on 2C-B. Visually, it created a light sheen and enhanced colouration, but there was little in the way of serious OEVs or CEVs. It is possible, or perhaps probable, that these may manifest with higher doses.
Insufflation was agony. I experimented with this RoA on several occasions, and each came with at least 24 hours of subsequent discomfort, which at times seemed to be bordering on the edge of a nasally driven head cold. As would be expected via this route, the onset was much faster and the duration was shorter, but the physical cost was higher and the trip itself was consequently less comfortable. Nasally, I usually dosed at around the 8mg level.
Overall 2C-B-FLY produced a decent ride, providing a more frivolous and physical contrast to my preferred psychedelics. The shorter duration was certainly an attraction, and with expectation set appropriately, it provided for an interesting trip.
2C-B-FLY was quickly adopted for resale by a variety of other vendors